Identification of cancer stem cells provides novel tumor models for drug discovery.

Frontiers of Medicine
Douglas D FangYajun Xu

Abstract

Cancer stem cells (CSCs) have received considerable attention from the research community since they were first reported in human acute myeloid leukemia 15 years ago. Accumulating evidence suggests that CSCs are responsible for tumor initiation and progression, drug resistance, and metastasis in both liquid and solid tumors. These findings lead to the development of novel compounds targeting CSC populations that is becoming increasingly important for eradicating CSCs in heterogeneous tumor masses and to cure the cancer. Since 2003, we have participated in CSC studies and encountered crucial early events in the field. This article reviews the history of CSC biology, clarifies the term and its definition, and further addresses the issue of how to utilize CSCs in therapeutic target discovery and drug development based on our substantial experience.

References

Nov 6, 1998·Science·J A ThomsonJ M Jones
Jan 5, 1999·Journal of Neuroscience Methods·C N SvendsenM A Caldwell
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·N UchidaI L Weissman
Nov 2, 2001·Nature·T ReyaI L Weissman
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Houman D HemmatiHarley I Kornblum
Jan 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Toru KondoTetsuya Taga
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·C Hirschmann-JaxM K Brenner
Nov 4, 2004·Journal of the National Cancer Institute·Matus StudenyMichael Andreeff
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Oct 19, 2005·Cancer Research·Dong FangMeenhard Herlyn
Dec 8, 2005·Neoplasia : an International Journal for Oncology Research·C Parker GibbsDennis A Steindler
May 26, 2006·The American Journal of Pathology·Hong YuXiaowei Xu
Nov 14, 2006·Biochemical and Biophysical Research Communications·Atsushi SuetsuguHisataka Moriwaki
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Dec 21, 2006·Journal of the National Cancer Institute·Tiffany M PhillipsFrank Pajonk
Jan 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·M E PrinceL E Ailles
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
Feb 27, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elena MonzaniCaterina A M La Porta
Jun 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Piero DalerbaMichael F Clarke
Oct 5, 2007·Nature·Antoine E KarnoubRobert A Weinberg
Dec 1, 2007·Cell Death and Differentiation·A EramoR De Maria
Jan 19, 2008·Nature·Tobias SchattonMarkus H Frank
Feb 5, 2008·Cancer Cell·Zhen Fan YangSheung Tat Fan
Jun 4, 2008·Cancer Research·Pravin J MishraDebabrata Banerjee
Feb 12, 2009·Cancer Research·Mario-Luca SuvàIvan Stamenkovic
Feb 13, 2009·International Journal of Oncology·Rebecca G BagleyBeverly A Teicher

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Sara Soltanian, Maryam M Matin
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Chao Ni, Jian Huang
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Zhiwei WangFazlul H Sarkar
© 2021 Meta ULC. All rights reserved